Powered by Google TranslateTranslate
Original text
Rate this translation
Your feedback will be used to help improve Google Translate
Latest Press Releases
View all
TimeHeadline
Just nowCentury Complete Announces New Homes Coming Soon to Fleming Island, FL
Just nowSprott Physical Copper Trust Announces Preliminary Proxy Results for Unitholder Meeting and Anticipated Listing Date on the NYSE Arca
1m agoTambourine & Hyatt Launch Hyatt Wedding Guide to Revolutionize Digital Wedding Planning
33m agoUFP Industries Expands Pallet Manufacturing Network Through Acquisition
34m agoPodcastOne (Nasdaq: PODC) Anticipates Record FY 2026 Results of $61M+ Revenue and $6.3M+ Adjusted EBITDA*, Up +1,476% YOY
Alnylam Pharmaceuticals Inc logo

Alnylam Pharmaceuticals Inc

About

Alnylam Pharmaceuticals Inc (NASDAQ:ALNY) — investor relations, events, news, and company updates on 6ix.

Latest News

Apr 16 2026
Alnylam to Webcast Conference Call Discussing First Quarter 2026 Financial Results
Mar 30 2026
New Data Presented at ACC.26 Further Support Benefits of Vutrisiran in ATTR-CM and Potential of Zilebesiran for Hypertension Management
Mar 24 2026
Viz.ai Partners with Alnylam Pharmaceuticals to Advance Earlier Identification and Care Coordination in Cardiac Amyloidosis
Mar 24 2026
Alnylam Advances Future of ATTR-CM Care Through Strategic Collaboration with Viz.ai and Support for the American Heart Association
Mar 10 2026
Alnylam to Webcast TTR Investor Webinar

Financials

Revenue
$3.71 B
Market Cap
$42.29 B
P/E Ratio
136.85
EPS
2.33

Community Chat

Ask AI

6ix6ix